CCL5 and breast carcinoma: Nonetheless, higher mRNA expression is associated with better prognosis in HER2+ breast cancer, similar to inconsistences between the metastatic potential and survival of HER2+ breast cancer for CCL5. NRP1 was overexpressed in basal breast cancer relative to other subtypes in METABRIC (Fig. 5e).